ITPD20000208A0 - Polisaccaridi percarbossilati, processo per la loro preparazione e loro impiego in campo farmaceutico e biomedico-sanitario. - Google Patents

Polisaccaridi percarbossilati, processo per la loro preparazione e loro impiego in campo farmaceutico e biomedico-sanitario.

Info

Publication number
ITPD20000208A0
ITPD20000208A0 IT2000PD000208A ITPD20000208A ITPD20000208A0 IT PD20000208 A0 ITPD20000208 A0 IT PD20000208A0 IT 2000PD000208 A IT2000PD000208 A IT 2000PD000208A IT PD20000208 A ITPD20000208 A IT PD20000208A IT PD20000208 A0 ITPD20000208 A0 IT PD20000208A0
Authority
IT
Italy
Prior art keywords
biomedical
pharmaceutical
preparation
health field
percarboxylated
Prior art date
Application number
IT2000PD000208A
Other languages
English (en)
Inventor
Davide Bellini
Vittorio Crescenzi
Andrea Francescangeli
Original Assignee
Fidia Advanced Biopolymers Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl
Publication of ITPD20000208A0 publication Critical patent/ITPD20000208A0/it
Priority to IT2000PD000208A priority Critical patent/IT1317359B1/it
Priority to EP01971988A priority patent/EP1339753A2/en
Priority to AU9181501A priority patent/AU9181501A/xx
Priority to AU2001291815A priority patent/AU2001291815B8/en
Priority to PCT/EP2001/010062 priority patent/WO2002018448A2/en
Priority to CA2420618A priority patent/CA2420618C/en
Priority to JP2002523962A priority patent/JP2004507586A/ja
Publication of ITPD20000208A1 publication Critical patent/ITPD20000208A1/it
Priority to US10/376,369 priority patent/US7683038B2/en
Application granted granted Critical
Publication of IT1317359B1 publication Critical patent/IT1317359B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/02—Alkyl or cycloalkyl ethers
    • C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/10—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
    • C08B11/12—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
IT2000PD000208A 2000-08-31 2000-08-31 Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e IT1317359B1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT2000PD000208A IT1317359B1 (it) 2000-08-31 2000-08-31 Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
PCT/EP2001/010062 WO2002018448A2 (en) 2000-08-31 2001-08-31 Percarboxylated polysaccharides, and a process for their preparation
AU9181501A AU9181501A (en) 2000-08-31 2001-08-31 Percarboxylated polysaccharides, and a process for their preparation
AU2001291815A AU2001291815B8 (en) 2000-08-31 2001-08-31 Percarboxylated polysaccharides, and a process for their preparation
EP01971988A EP1339753A2 (en) 2000-08-31 2001-08-31 Percarboxylated polysaccharides, and a process for their preparation
CA2420618A CA2420618C (en) 2000-08-31 2001-08-31 Percarboxylated polysaccharides, and a process for their preparation
JP2002523962A JP2004507586A (ja) 2000-08-31 2001-08-31 過カルボン酸エステル化された多糖類、及びそれらの作製方法
US10/376,369 US7683038B2 (en) 2000-08-31 2003-02-28 Percarboxylated polysaccharides, and a process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000PD000208A IT1317359B1 (it) 2000-08-31 2000-08-31 Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e

Publications (3)

Publication Number Publication Date
ITPD20000208A0 true ITPD20000208A0 (it) 2000-08-31
ITPD20000208A1 ITPD20000208A1 (it) 2002-03-03
IT1317359B1 IT1317359B1 (it) 2003-06-16

Family

ID=11452056

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000PD000208A IT1317359B1 (it) 2000-08-31 2000-08-31 Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e

Country Status (7)

Country Link
US (1) US7683038B2 (it)
EP (1) EP1339753A2 (it)
JP (1) JP2004507586A (it)
AU (2) AU2001291815B8 (it)
CA (1) CA2420618C (it)
IT (1) IT1317359B1 (it)
WO (1) WO2002018448A2 (it)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20020003A1 (it) * 2002-01-11 2003-07-11 Fidia Advanced Biopolymers Srl Biomateriali a base di acido ialuronico come terapia anti-angiogenicanella cura dei tumori.
ITPD20020271A1 (it) 2002-10-18 2004-04-19 Fidia Farmaceutici Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati.
WO2004060404A1 (ja) * 2002-12-27 2004-07-22 Chugai Seiyaku Kabushiki Kaisha 薬物担体
FR2862979B1 (fr) * 2003-11-28 2006-03-10 Centre Nat Rech Scient Boites bioactives pour cultures cellulaires
US7879994B2 (en) 2003-11-28 2011-02-01 Eastman Chemical Company Cellulose interpolymers and method of oxidation
ITPD20040053A1 (it) * 2004-02-27 2004-05-27 Fidia Advanced Biopolymers Srl Biomateriali costituiti da derivati dell'acido ialuronico come nuova terapia di cura per la protezione e la la riparazione della cartilagine articolare danneggiata per osteoartrosi
ITPD20040245A1 (it) * 2004-10-08 2005-01-08 Fidia Advanced Biopolymers Srl Biomateriali costituiti da acido ialuronico solfatato e gellano utilizzabili nella prevenzione delle adesioni spinali
ITPD20050206A1 (it) * 2005-07-07 2007-01-08 Fidia Advanced Biopolymers Srl Biomateriali in forma di fibra da impiegarsi come dispositivi medici nel trattamento delle ferite e loro processi di produzione
ITMI20051415A1 (it) * 2005-07-22 2007-01-23 Fidia Advanced Biopolymers Srl Biomateriali a base di corbossimetilcellulosa salificata con zinco associata a derivati dell'acido ialuronico da impiegarsi come dispositivi medici con attivita' antimicrobica ed antifungina e loro processo di produzione
ITPD20050242A1 (it) 2005-08-03 2007-02-04 Fidia Farmaceutici Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
IE20060565A1 (en) * 2006-07-28 2008-02-06 Eurand Pharmaceuticals Ltd Drug delivery system based on regioselectively amidated hyaluronic acid
ITMI20071267A1 (it) 2007-06-22 2008-12-23 Fidia Farmaceutici Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative
ITMI20071724A1 (it) 2007-09-05 2009-03-06 Fidia Farmaceutici Formulazioni topiche antivirali in forma di gel bioadesivo
CN104888264B (zh) 2008-01-14 2018-01-09 北京环球利康科技有限公司 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料
PT103970A (pt) * 2008-02-15 2009-08-17 Ass For The Advancement Of Tis Hidrogéis à base de goma gelana para utilização em medicina regenerativa e engenharia de tecidos, seu sistema e dispositivos de processamento
AU2009231634B2 (en) * 2008-04-04 2014-05-15 University Of Utah Research Foundation Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
US8343942B2 (en) 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
IT1399351B1 (it) 2009-06-16 2013-04-16 Fidia Farmaceutici Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
CZ302504B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
WO2011119059A1 (en) * 2010-03-26 2011-09-29 Association For The Advancement Of Tissue Engineering And Cell Based Technologies And Therapies - A4Tec Photo-crosslinked gellan gum-based hydrogels: preparation methods and uses thereof
BR112012024877A2 (pt) * 2010-04-08 2016-06-14 Merz Pharma Gmbh & Co Kgaa preenchedor, processo para o preparo de um preenchedor e dispositivo de injeção
US20160145567A1 (en) * 2010-05-27 2016-05-26 Corning Incorporated Cell culture article and methods thereof
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
US11407978B2 (en) 2010-10-25 2022-08-09 Albert-Ludwigs-Universität Freiburg Extracellular matrices which can be used as scaffold for living cells
IT1402786B1 (it) 2010-11-19 2013-09-18 Fidia Farmaceutici Composizioni farmaceutiche ad attivita' antibatterica e cicatrizzante
WO2012113529A1 (en) * 2011-02-22 2012-08-30 Merz Pharma Gmbh & Co. Kgaa In situ formation of a filler
CA2830933A1 (en) 2011-03-23 2012-09-27 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
CZ304072B6 (cs) * 2011-04-26 2013-09-25 Contipro Biotech S.R.O. Amfoterní materiál na bázi sítované kyseliny hyaluronové, zpusob jeho prípravy, materiály obsahující aktivní cinidla uzavrené v síti hyaluronanu, zpusob jejich prípravy a jejich pouzití
EP2744832B1 (en) 2011-08-18 2021-04-21 Albert-Ludwigs-Universität Freiburg Matrices comprising a modified polysaccharide
CZ2012136A3 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
ITMI20120664A1 (it) * 2012-04-20 2013-10-21 Anika Therapeutics Srl Biomateriali a base di gellano per l'uso come filler in chirurgia
WO2013188534A1 (en) * 2012-06-12 2013-12-19 Rutgers, The State University Of New Jersey Biomaterials for the prevention of post-operative adhesions
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
CZ304266B6 (cs) * 2012-11-27 2014-02-05 Contipro Biotech S.R.O. Nekonečná vlákna na bázi hyaluronanu selektivně oxidovaného v poloze 6 N-acetyl-D-glukosaminové části, jejich příprava, použití, nitě, střiže, příze, textilie a způsob jejich úpravy
DE202013012275U1 (de) 2013-04-23 2015-12-18 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Kit zum Herstellen eines vernetzten Gels zum Umschließen von Nierensteinen und/oder Nierensteinfragmenten
DE202013012287U1 (de) 2013-04-23 2016-01-18 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Gelbildendes System zum Entfernen von Nierensteinfragmenten
EP2796101B1 (de) 2013-04-23 2016-04-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Kit zum Herstellen eines vernetzten Gels zum Umschließen von Nierensteinen und/oder Nierensteinfragmenten
PL2796100T3 (pl) 2013-04-23 2016-08-31 Fraunhofer Ges Forschung Układ tworzący żel do usuwania fragmentów kamieni nerkowych
ITMI20131971A1 (it) * 2013-11-26 2015-05-27 Fidia Farmaceutici Composizioni farmaceutiche ad attività idratante e lubrificante
CZ305153B6 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CN107073031B (zh) 2014-06-15 2021-08-24 耶达研究及发展有限公司 利用水溶性聚合物和脂质/脂质体的表面处理
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ2015398A3 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
EP3448394B1 (en) 2016-04-27 2023-09-13 Anika Therapeutics, Inc. Compositions for use in treating tendon degeneration
JP6139754B1 (ja) * 2016-06-17 2017-05-31 株式会社ユーグレナ 細胞増殖促進剤
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
WO2020144372A1 (en) 2019-01-10 2020-07-16 The Provost, Fellows, Scholars And Other Members Of Board Of Trinity College Dublin Composite viscoelastic hydrogel, and uses thereof for sealing a channel in tissue
AU2019207781A1 (en) 2018-01-10 2020-07-30 The Provost, Fellows, Scholars And Other Members Of Board Of Trinity College Dublin System and methods for sealing a channel in tissue
IT201900006250A1 (it) 2019-04-23 2020-10-23 Fidia Farm Spa Medicazione per il trattamento della cute lesa
EP3976123A1 (en) 2019-05-31 2022-04-06 University College Dublin Hyaluronic acid-based hybrid hydrogel
CN113509590B (zh) * 2021-06-07 2022-09-09 广东唯泰生物科技有限公司 外泌体联合透明质酸的伤口敷料及其制备方法和应用
IT202100032111A1 (it) 2021-12-22 2023-06-22 Fidia Farm Spa Nuovi sostituti biocompatibili dell’umor vitreo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US4746504A (en) * 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
NL1000495C2 (nl) * 1995-06-02 1996-12-03 Avebe Coop Verkoop Prod Geoxideerde polymere koolhydraatethers voor toepassing als sequestreer- middel, alsmede werkwijzen ter bereiding daarvan.
JPH10204102A (ja) * 1997-01-27 1998-08-04 Mitsubishi Gas Chem Co Inc 水溶性トリカルボキシ多糖類の製造方法
ATE229038T1 (de) * 1997-04-04 2002-12-15 Fidia Advanced Biopolymers Srl N-sulfatierte hyaluronsäureverbindungen, ihre derivate und verfahren zu ihrer herstellung
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
ITPD980169A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US6586588B1 (en) * 1999-08-17 2003-07-01 National Starch And Chemical Investment Holding Corporation Polysaccharide aldehydes prepared by oxidation method and used as strength additives in papermaking

Also Published As

Publication number Publication date
US7683038B2 (en) 2010-03-23
CA2420618A1 (en) 2002-03-07
AU2001291815B8 (en) 2006-03-30
US20030181689A1 (en) 2003-09-25
AU9181501A (en) 2002-03-13
AU2001291815B2 (en) 2006-03-02
WO2002018448A2 (en) 2002-03-07
IT1317359B1 (it) 2003-06-16
CA2420618C (en) 2012-01-03
JP2004507586A (ja) 2004-03-11
EP1339753A2 (en) 2003-09-03
WO2002018448A3 (en) 2002-05-16
ITPD20000208A1 (it) 2002-03-03

Similar Documents

Publication Publication Date Title
ITPD20000208A0 (it) Polisaccaridi percarbossilati, processo per la loro preparazione e loro impiego in campo farmaceutico e biomedico-sanitario.
EE200300236A (et) 1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod
EE200300370A (et) Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
EE200300369A (et) Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
HUP0300209A3 (en) Lipid nanocapsules, preparation method and use as medicine
NO20014963D0 (no) Cycloalkyl-substituerte benzimidazoler, samt fremstilling og anvendelse derav
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
EE05109B1 (et) Sulfoonamiidi derivaadid, nende kasutamine meditsiinis ning meetod nende valmistamiseks
HK1053118A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof.
MXPA03000873A (es) Derivados de quinazolina, medicamentos que contienen estos compuestos, su uso y metodos para la produccion de los mismos.
ITRM20020529A0 (it) Polimeri sterilizzanti, processo di loro preparazione ed uso.
IT1305313B1 (it) 3,4 - diidro- 6- benzil-4-oxopirimidine sostituite e relativo processodi produzione e impiego nella terapia delle infezioni da hiv-1.
BR0318172B1 (pt) "dispositivo de combinaÇço de impedÂncia, e, mÉtodo para fabricar o mesmo"
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
EE200300060A (et) Polaarsete rühmadega perfluoroalküülrühma sisaldavad kompleksid, nende valmistamismeetod ja kasutamine
ITFI940009A0 (it) Antagonisti delle tachichinine, loro preparazione e formulazioni farmaceutiche che li contengono.
IT1317356B1 (it) Derivati della cumarina e relativi sali, processo per la loropreparazione e loro impiego in campo farmaceutico.
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
IL156162A0 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof.
IT1313700B1 (it) Composizioni anti-incrostazione e loro impiego nei processi dipolimerizzazione.
MXPA03006744A (es) Derivados sustituidos de propan-1,3-diamina y su uso farmaceutico.
MXPA03007550A (es) Derivados coloporosidos, proceso para su preparacion y su uso.
AU2002246095A1 (en) Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
ITTO20020674A0 (it) Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico
HK1052709A1 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof pluraflavin.